pharmaceutical investing Final Patient Completes Treatment in First Leg of OncBioMune's Clinical Trial
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake